DUBLIN–(BUSINESS WIRE)–The “Glycomics Market Size, Share & Trends Analysis Report By Product (Enzymes, Kits, Reagents, Instruments), By Application (Drug Discovery & Development, Diagnostics), By End Use, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.
The global glycomics market size is expected to reach USD 4.92 billion by 2030 and is estimated to register a CAGR of 14.6% during 2023-2030
Growing research and development in the glycomics space, owing to its crucial role in various biological processes, is projected to drive the global market. Moreover, the increasing demand for personalized medicine has further supported industry growth as glycomics plays a significant role in developing glycan-based diagnostic solutions.
Recently glycomics have shown promise in identifying disease-specific glycan biomarkers for early detection and diagnosis of various health conditions. The potential for glycan biomarkers has attracted interest from the healthcare and diagnostics industries. For instance, in November 2021 GlycoPath Inc. launched its glycan imaging kit for glycoproteomic analysis of clinical and research samples. The newly launched kit is applicable for tissue imaging to biofluid profiling and is easily adaptable with many kinds of platforms.
Technological advancements have also contributed to the high demand for glycomics instruments. Procedures such as protein characterizations are evolving into advanced technologies such as Mass Spectrometry (MS), High-Performance Liquid Chromatography (HPLC), and Capillary Electrophoresis (CE) in chemical and biochemical research. These advanced techniques provide rapid and precise results. Glycomics technologies currently available are standardized and streamlined.
Furthermore, the increase in the number of research institutes that support glycan-based research is a major factor anticipated to fuel market growth in the near future. The National Center for Biomedical Glycomics (NCBG) focuses on the dissemination & development of technologies and tools for analytical genomics.
The organization’s analytical, technical R&D program involves the development of glycan tools, glycoconjugate, and informatics. In addition, the National Cancer Institute consists of the Alliance of Glycobiologists for Cancer Research, which aims at studying the structure as well as functions of glycans for cancer study.
Glycomics Market Report Highlights
- Enzymes segment dominated the industry in 2022 with a revenue share of 29.2% and is attributed to the wide application of enzymes in glycan-based studies, diagnostics, and drug discovery
- Drug discovery and development is the largest application of the market, whereas the diagnostics segment is expected to witness the fastest growth owing to the growing interest of industry players in developing glycan-based diagnostics
- In the end-use segment, the academic & research institutes segment dominated the market with a revenue share of 38.2%. The higher revenue growth is attributed to the extensive adoption of glycan structure data analysis by research centers and the increasing preference for glycomics for training & educational purposes
- North America region dominated the global market in 2022 with a revenue share of 39.1%. The high growth of the region is governed by factors such as the presence of a large number of research institutes and supportive government legislation.
Competitive Landscape
- Thermo Fisher Scientific, Inc
- Merck KGaA
- Agilent Technologies Inc.
- Bruker
- New England Biolabs
- Shimadzu Corporation
- Waters Corporation
- Takara Bio Inc
- Asparia Glycomics
- RayBiotech Life, Inc.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2022 – 2030 |
| Estimated Market Value (USD) in 2022 | $1.65 Billion |
| Forecasted Market Value (USD) by 2030 | $4.92 Billion |
| Compound Annual Growth Rate | 14.6% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing focus on glycomics and proteomics research
3.2.1.2. Rising R & D investments by pharmaceutical and biotechnology companies
3.2.1.3. Technological advancements
3.2.1.4. Increasing focus on developing alternative to animal testing
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of glycomics instruments
3.2.2.2. Stringent government policies and regulations
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Glycomics Market: Product Movement Analysis
4.2. Enzymes
4.2.1. Enzymes Market, 2018 – 2030 (USD Million)
4.2.2. Glycosidases
4.2.3. Glycosyltransferases
4.2.4. Neuraminidases
4.2.5. Sialyltransferases
4.3. Kits
4.3.1. Kits Market, 2018 – 2030 (USD Million)
4.3.2. Glycan labeling kits
4.3.3. Glycan purification kits
4.3.4. Glycan release kits
4.4. Reagents
4.4.1. Reagents Market, 2018 – 2030 (USD Million)
4.4.2. Glycoproteins
4.4.3. Monosaccharides
4.4.4. Oligosaccharides
4.5. Instruments
4.5.1. Instruments Market, 2018 – 2030 (USD Million)
4.5.2. Mass spectrometers
4.5.3. HPLC
4.5.4. MALDI-TOF
4.5.5. Array systems
Chapter 5. Application Business Analysis
5.1. Glycomics Market: Application Movement Analysis
5.2. Drug Discovery & Development
5.2.1. Drug Discovery & Development Market, 2018 – 2030 (USD Million)
5.3. Diagnostics
Chapter 6. End Use Business Analysis
6.1. Glycomics Market: End Use Movement Analysis
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 – 2030 (USD Million)
6.3. Academic & Research Institutes
6.4. Biopharmaceutical Companies
6.5. CROs
Chapter 7. Regional Business Analysis
7.1. Glycomics Market Share By Region, 2022 & 2030
For more information about this report visit https://www.researchandmarkets.com/r/z8kknl
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900